Insider trade

Zymeworks (ZYME): Director bought ~$690K

EcoR1 Capital, Director at Zymeworks, bought ~$690K of Zymeworks shares.

~$690K
Approx. value · 54K sh @ $12.91
17.2M
Holds after · shares reported
Traded
Mar 25, 2025
Filed
Mar 27, 2025

What stands out in this filing

  • The purchase added 0.3% to the shares this insider held before it; the filing reports 17,211,303 shares, held indirectly afterwards.
  • 53,501 shares at an average of $12.91 each, as reported on the form.
  • The first open-market purchase by this insider in 0 months.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 11, 2025InsiderDirector purchased ~$3.69M of ZYME shares in the open market
  2. Mar 12, 2025InsiderDirector purchased ~$3.59M of ZYME shares in the open market
  3. Mar 13, 2025InsiderDirector purchased ~$5.85M of ZYME shares in the open market
  4. Mar 17, 2025InsiderDirector purchased ~$688K of ZYME shares in the open market
  5. Mar 18, 2025InsiderDirector purchased ~$1.44M of ZYME shares in the open market
  6. Mar 19, 2025InsiderDirector purchased ~$737K of ZYME shares in the open market
  7. Mar 20, 2025InsiderDirector purchased ~$950K of ZYME shares in the open market
  8. Mar 21, 2025InsiderDirector purchased ~$397K of ZYME shares in the open market
  9. Mar 24, 2025InsiderDirector purchased ~$297K of ZYME shares in the open market
  10. Mar 25, 2025 · this disclosureInsiderDirector purchased ~$690K of ZYME shares in the open market

What came next

  1. Mar 26, 2025InsiderDirector purchased ~$537K of ZYME shares in the open market
  2. Mar 31, 2025InsiderDirector purchased ~$52K of ZYME shares in the open market
  3. Apr 1, 2025InsiderDirector purchased ~$565K of ZYME shares in the open market
  4. Apr 2, 2025InsiderDirector purchased ~$881K of ZYME shares in the open market
  5. Apr 3, 2025InsiderDirector purchased ~$1.43M of ZYME shares in the open market
  6. Apr 4, 2025InsiderDirector purchased ~$2.19M of ZYME shares in the open market
  7. Apr 16, 2025InsiderDirector purchased ~$826K of ZYME shares in the open market
  8. Apr 17, 2025InsiderDirector purchased ~$631K of ZYME shares in the open market
  9. May 15, 2025InsiderDirector purchased ~$566K of ZYME shares in the open market
  10. May 19, 2025InsiderDirector purchased ~$70K of ZYME shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Zymeworks

For Zymeworks, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZYME page.

Other recent filings by EcoR1 Capital, LLC, Director

The full history of EcoR1 Capital, LLC, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Zymeworks (ZYME) insider traded, and how much?

EcoR1 Capital, Director at Zymeworks, bought ~$690K of Zymeworks shares. 54K shares at $12.91, open market.

When did it happen, and when was it made public?

Traded: Mar 25, 2025. Filed: Mar 27, 2025. That is 2 days between the two dates.

What stands out in this filing?

The purchase added 0.3% to the shares this insider held before it; the filing reports 17,211,303 shares, held indirectly afterwards. 53,501 shares at an average of $12.91 each, as reported on the form. The first open-market purchase by this insider in 0 months.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Zymeworks recently?

For Zymeworks, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ZYME page.

Does this mean ZYME stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Zymeworks

Everything OQRO holds on this company is on its ZYME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data